Yahoo
    Shanghai CNY

    Kangmei Pharmaceutical Co., Ltd. (600518.SS)

    1.2800 +0.0200 (+1.59%)
    At close: October 30 at 3:00:02 PM GMT+8
    Chart Range Bar
    Advanced Chart
    AlphaSpace Chart
    Loading chart for 600518.SS
    • Previous Close 1.2600
    • Open 1.2500
    • Bid 1.2800 x --
    • Ask 1.2900 x --
    • Day's Range 1.2400 - 1.3100
    • 52 Week Range 1.1600 - 2.1600
    • Volume 218,866,127
    • Avg. Volume 159,294,677
    • Market Cap (intraday) 17.701B
    • Beta (5Y Monthly) --
    • PE Ratio (TTM) --
    • EPS (TTM) 0.0000
    • Earnings Date --
    • Forward Dividend & Yield -- (0.00%)
    • Ex-Dividend Date Aug 28, 2019
    • 1y Target Est --

    Kangmei Pharmaceutical Co., Ltd. produces and sells Chinese herbal medicines in China. The company offers Chinese patent medicines, chemical medicines, and health food products. It also engages in the operation of Chinese medicinal materials markets; production and sale of medical devices; and operation of pharmaceutical logistics system. The company provides its products through medical institution resources, smart pharmacies, OTC retail, chain drug stores, direct sales, medical e-commerce, mobile medical care, etc. Kangmei Pharmaceutical Co., Ltd. was incorporated in 1997 and is based in Shenzhen, China.

    www.kangmei.com.cn

    5,492

    Full Time Employees

    December 31

    Fiscal Year Ends

    Healthcare

    Sector

    Drug Manufacturers - Specialty & Generic

    Industry

    More about Kangmei Pharmaceutical Co., Ltd.

    Recent News

    View More
    View More

    Performance Overview

    Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .

    YTD Return

    600518.SS
    32.98%
    SSE Composite Index (000001.SS)
    9.32%

    1-Year Return

    600518.SS
    37.25%
    SSE Composite Index (000001.SS)
    9.73%

    3-Year Return

    600518.SS
    32.28%
    SSE Composite Index (000001.SS)
    19.11%

    5-Year Return

    600518.SS
    71.74%
    SSE Composite Index (000001.SS)
    1.46%

    Earnings Trends

    View More

    Earnings Per Share

    Revenue vs. Earnings

    Annual
    Quarterly
    Annual
    Quarterly
    Q3 FY18
    Revenue 8.47B
    Earnings --
    Profit Margin 0.00%

    Q4

    FY17

    Q1

    FY18

    Q2

    FY18

    Q3

    FY18

    0
    2B
    4B
    6B
    8B
    0.0%
    View More

    Statistics

    View More

    Valuation Measures

    Annual

    • Market Cap

    • Enterprise Value

    • Trailing P/E

    • Forward P/E

    • PEG Ratio (current)

    • Price/Sales (ttm)

    • Price/Book (mrq)

    • Enterprise Value/Revenue

    • Enterprise Value/EBITDA

    Financial Highlights

    Profitability and Income Statement

    • Profit Margin

      1.88%

    • Return on Assets (ttm)

      -1.14%

    • Return on Equity (ttm)

      1.27%

    • Revenue (ttm)

      4.82B

    • Net Income Avi to Common (ttm)

      90.65M

    • Diluted EPS (ttm)

      0.0000

    Balance Sheet and Cash Flow

    • Total Cash (mrq)

      1.36B

    • Total Debt/Equity (mrq)

      2.05%

    • Levered Free Cash Flow (ttm)

      -382.73M

    View More

    Company Insights

    Research Reports

    View More
    View More

    People Also Watch

    601162.SS Tianfeng Securities Co., Ltd.
    3.1700 -2.46%
    002520.SZ Zhejiang RIFA Precision Machinery Co., Ltd.
    6.20 +0.16%
    ATLA.JK PT Atlantis Subsea Indonesia Tbk
    20.00 -4.76%
    600383.SS Gemdale Corporation
    2.0900 -0.48%
    000826.SZ TUS Environmental Science and Technology Development Co., Ltd.
    1.8200 +1.11%
    Mobilize your Website
    View Site in Mobile | Classic
    Share by: